Legal Representation
Attorney
Frances M. Jagla
Application History
27 events| Date | Code | Type | Description |
|---|---|---|---|
| Mar 18, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Mar 18, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Mar 18, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Jan 21, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jan 21, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jan 21, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jan 21, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jan 21, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jan 21, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jan 15, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jan 15, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jan 15, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Oct 25, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Oct 25, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Oct 25, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Oct 23, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| Oct 23, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| Oct 23, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| Sep 16, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Sep 16, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sep 16, 2024 | NWAP | I | NEW APPLICATION ENTERED |
| Sep 16, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Sep 16, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sep 16, 2024 | NWAP | I | NEW APPLICATION ENTERED |
| Sep 16, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Sep 16, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sep 16, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of dermatological disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of fibrotic disorders; pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of graft versus host disorder (GVHD)
Class 016
Printed brochures, newsletters, and pamphlets in the fields of medical issues, procedures, disease symptoms, patient support and community building
Class 044
Providing medical information to healthcare providers and patients relating to viral, hematological, auto-immune, graft versus host, inflammatory, metabolic, fibrotic, skeletal, chondrocyte and dermatological disorders
Classification
International Classes
005
016
044